Institute of Pathology, Spedali Civili, Brescia, Italy.
Department of Diagnostic, Clinic and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Pathologica. 2021 Feb;113(1):39-53. doi: 10.32074/1591-951X-235.
Inflammatory bowel diseases (IBDs) are lifelong disorders in which an interaction between genetic and environmental factors is involved. IBDs include two entities: Crohn's disease (CD) and ulcerative colitis (UC); these can be adequately diagnosed and distinguished with a correct methodological approach based on communicating exhaustive clinical, endoscopic and laboratory information to the pathologist and performing adequate bioptic sampling and precise morphological signs including crypt architecture, distribution of inflammation and granulomas, when present. IBD needs to be distinguished from non-IBD colitis, mostly at its onset. Moreover, IBDs are associated with an increased risk of developing colorectal adenocarcinoma. In daily pathological practice, correct diagnosis of IBD and its subclassification as well as a correct detection of dysplasia is imperative to establish the best therapeutic approach.
炎症性肠病(IBD)是一种终身性疾病,涉及遗传和环境因素的相互作用。IBD 包括两种疾病:克罗恩病(CD)和溃疡性结肠炎(UC);通过正确的方法学方法,可以充分诊断和区分这些疾病,该方法基于将详尽的临床、内镜和实验室信息传达给病理学家,并进行充分的活检采样和精确的形态学特征,包括隐窝结构、炎症分布和肉芽肿,在存在时。需要将 IBD 与非 IBD 结肠炎区分开来,尤其是在疾病初期。此外,IBD 还会增加结直肠腺癌的发病风险。在日常病理实践中,正确诊断 IBD 及其亚型以及正确检测异型增生对于确定最佳治疗方法至关重要。